ADVENZYMES Advanced Enzyme Technologies Limited
Healthcare
LTP
264.4
CHG · %
+4.55 (+1.75%)
VOL · TODAY
2.55L
PREV CLOSE
259.85
Today's range258 · 266.1
264.4
52-week range246.8 · 419
264.4
Loading candles…
Advanced Enzyme Technologies Limited is a company engaged in the research, development, commercial-scale manufacturing, and global marketing of enzyme and probiotic products. Operating within the enzymes, probiotics, human nutrition, animal nutrition, and industrial bio-processing industries, it offers over 400 proprietary products developed from more than 68 enzymes and probiotics. The company serves over 700 customers across more than 45 countries. It is recognized as the largest enzyme company in India and is the second-largest integrated enzyme player listed globally. Advanced Enzyme Technologies Limited is publicly traded, although no information about its founders, key management, or headquarters is provided.
ADVENZYMES is not part of any active scan today.
This page is a live market overview for Advanced Enzyme Technologies L (ADVENZYMES) on the BSE. As a listed security, Advanced Enzyme Technologies L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ADVENZYMES before placing trades on tick2trade.
As of the latest feed, ADVENZYMES last traded at ₹264.4 on BSE, up ₹4.55 (1.75%) from the previous close of ₹259.85. Today's session range is ₹258 – ₹266.1, against a 52-week band of ₹246.8 – ₹419. Traded volume today stands at 2.55L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ADVENZYMES in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ADVENZYMES is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Advanced Enzyme Technologies L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ADVENZYMES. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ADVENZYMES option chain page linked from this overview.
// similar in healthcare326 total